IAA
SPPI

Independent Advisor Alliance’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Independent Advisor Alliance’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-10,800
Closed -$8.1K – 706
2023
Q1 		$8.1K Hold
10,800
– – ﹤0.01% 667
2022
Q4 		$4 Hold
10,800
– – ﹤0.01% 420
2022
Q3 		$5K Buy
+10,800
New +$10.6K ﹤0.01% 623

Other funds holding SPPI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NYLIM
New York Life Investment Management New York $11.8B AUM 23.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Independent Advisor Alliance's SPPI Position: Q2 2023 in Review

Independent Advisor Alliance sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q2 2023, closing a stake of 10,800 shares — an estimated $8.1K sold.

Independent Advisor Alliance first reported a position in SPPI in Q3 2022 and held it in 3 quarters. The position peaked at $8.1K in Q1 2023. 78 funds tracked by Wall St. Rank hold SPPI as of Q2 2023.

  • Independent Advisor Alliance reported no remaining Spectrum Pharmaceuticals Inc position as of Q2 2023 after selling out during the quarter.
  • Independent Advisor Alliance sold 10,800 Spectrum Pharmaceuticals Inc shares in Q2 2023, an estimated $8.1K.
  • Independent Advisor Alliance first reported a position in Spectrum Pharmaceuticals Inc in Q3 2022 and held it in 3 quarters.
  • Independent Advisor Alliance's Spectrum Pharmaceuticals Inc position peaked at $8.1K in Q1 2023.
  • 78 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q2 2023.

Based on Independent Advisor Alliance's 13F filing for Q2 2023, filed 28 Jul 2023.